Finanzen von WORK Medical Technology Group Ltd (WOK)WOKWORK Medical Technology Group Ltd

Evaluating the bottom line, WORK Medical Technology Group Ltd maintains a gross margin of 19.14%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -65.35%, while the net margin is -63.95%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively WOK converts its operational activities into shareholder value.

In the context of the broader market, WOK competes directly with industry leaders such as CELZ and NVNO. With a market capitalization of $4.23M, it holds a significant position in the sector. When comparing efficiency, WOK's gross margin of 19.14% stands against CELZ's N/A and NVNO's N/A. Such benchmarking helps identify whether WORK Medical Technology Group Ltd is trading at a premium or discount relative to its financial performance.

The gross margin has improved to 34.38% in Q3 2025, but the company has shown a net margin of only 0.29%, indicating limited profitability. Total equity has increased from 12.95 million USD to 30.13 million USD over the last year, but the company still operates at a loss with a negative P/E ratio.